Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A prospective study of type 2 diabetes, metformin use, and risk of breast cancer

Annals of Oncology(2021)10.1016/j.annonc.2020.12.008Source: DataRank Database

A prospective study of type 2 diabetes, metformin use, and risk of breast cancer is a research paper published in Annals of Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 101 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access101 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 5.92)OA: bronzeTopics (44)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Deborah B. Bookwalter,Katie M. O’Brien ORCID,Chandra L. Jackson ORCID,Clarice R. Weinberg ORCID,Dale P. Sandler ORCID

Live enrichment

PubMed:33516778 PMC:PMC7995619 OpenAlex:https://openalex.org/W3124905289

Intramural NIH HHS

Grant: Z01 ES044005

Intramural NIH HHS

Grant: ZIA ES103325

National Institute of Environmental Health Sciences

FWCI

5.92

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.annalsofoncology.org/article/S0923753420432144/pdf

publisherhttp://www.annalsofoncology.org/article/S0923753420432144/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0923753420432144?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0923753420432144?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.annonc.2020.12.008

Fields of Study

Metabolism, Diabetes, and CancerCancer Risks and FactorsCancer, Lipids, and MetabolismAdultAgedBreast NeoplasmsDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMetforminMiddle AgedProportional Hazards ModelsProspective StudiesRisk Factors

MeSH Terms

AdultAgedBreast NeoplasmsDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMetforminMiddle AgedProspective StudiesRisk FactorsProportional Hazards Models

Keywords

MedicineBreast cancerHazard ratioMetforminInternal medicineType 2 diabetesCancerOncologyDiabetes mellitusProspective cohort studyConfidence intervalGynecologyEndocrinologyInsulinEstrogen receptorTriple-negativeAntidiabetic Medication

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis

10.6084/m9.figshare.24761496.v1figshare

Additional file 1 of Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis

10.6084/m9.figshare.24761496figshare

Additional file 2 of Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus

10.6084/m9.figshare.25596531.v1figshare

Additional file 2 of Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus

10.6084/m9.figshare.25596531figshare

Additional file 2 of Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer

10.6084/m9.figshare.26573959.v1figshare

Additional file 2 of Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer

10.6084/m9.figshare.26573959figshare

Additional file 3 of Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus

10.6084/m9.figshare.26705508figshare

Additional file 3 of Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus

10.6084/m9.figshare.26705508.v1figshare

Additional file 1 of Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus

10.6084/m9.figshare.25596489.v1figshare

Additional file 1 of Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus

10.6084/m9.figshare.25596489figshare

Additional file 1 of Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer

10.6084/m9.figshare.26573956figshare

Additional file 1 of Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer

10.6084/m9.figshare.26573956.v1figshare